KR20010075698A - 베타 아고니스트 및 추가의 항당뇨병제를 포함하는 병용제 - Google Patents

베타 아고니스트 및 추가의 항당뇨병제를 포함하는 병용제 Download PDF

Info

Publication number
KR20010075698A
KR20010075698A KR1020017005958A KR20017005958A KR20010075698A KR 20010075698 A KR20010075698 A KR 20010075698A KR 1020017005958 A KR1020017005958 A KR 1020017005958A KR 20017005958 A KR20017005958 A KR 20017005958A KR 20010075698 A KR20010075698 A KR 20010075698A
Authority
KR
South Korea
Prior art keywords
yloxy
insulin
ethylamino
carbazol
hydroxyethyl
Prior art date
Application number
KR1020017005958A
Other languages
English (en)
Korean (ko)
Inventor
조나단 로버트 샌더스 아취
Original Assignee
피터 기딩스
스미스클라인비이참피이엘시이
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9824789.3A external-priority patent/GB9824789D0/en
Priority claimed from GBGB9824790.1A external-priority patent/GB9824790D0/en
Priority claimed from GBGB9824791.9A external-priority patent/GB9824791D0/en
Application filed by 피터 기딩스, 스미스클라인비이참피이엘시이 filed Critical 피터 기딩스
Publication of KR20010075698A publication Critical patent/KR20010075698A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
KR1020017005958A 1998-11-11 1999-11-11 베타 아고니스트 및 추가의 항당뇨병제를 포함하는 병용제 KR20010075698A (ko)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GBGB9824789.3A GB9824789D0 (en) 1998-11-11 1998-11-11 Novel method of treatment
GBGB9824790.1A GB9824790D0 (en) 1998-11-11 1998-11-11 Novel method of treatment
GBGB9824791.9A GB9824791D0 (en) 1998-11-11 1998-11-11 Novel methods of treatment
GB9824789.3 1998-11-11
GB9824790.1 1998-11-11
GB9824791.9 1998-11-11
PCT/GB1999/003755 WO2000027434A1 (en) 1998-11-11 1999-11-11 Combinations comprising a beta-agonist and a further antidiabetic agent

Publications (1)

Publication Number Publication Date
KR20010075698A true KR20010075698A (ko) 2001-08-09

Family

ID=27269550

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020017005958A KR20010075698A (ko) 1998-11-11 1999-11-11 베타 아고니스트 및 추가의 항당뇨병제를 포함하는 병용제

Country Status (15)

Country Link
EP (1) EP1128845A1 (hu)
JP (1) JP2002529430A (hu)
KR (1) KR20010075698A (hu)
CN (1) CN1332638A (hu)
AU (1) AU766928B2 (hu)
BR (1) BR9915214A (hu)
CA (1) CA2350062A1 (hu)
CZ (1) CZ20011655A3 (hu)
HK (1) HK1041201A1 (hu)
HU (1) HUP0104388A3 (hu)
IL (1) IL143004A0 (hu)
NO (1) NO20012300L (hu)
PL (1) PL348154A1 (hu)
TR (1) TR200101336T2 (hu)
WO (1) WO2000027434A1 (hu)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007201729B2 (en) * 1999-12-23 2010-02-25 Novartis Ag Use of hypoglycemic agent for treating impaired glucose metabolism
AU777776B2 (en) 1999-12-23 2004-10-28 Novartis Ag Use of hypoglycemic agent for treating impaired glucose metabolism
WO2001047509A2 (en) * 1999-12-24 2001-07-05 Smithkline Beecham P.L.C. Composition for the treatment diabetes mellitus containing an insuline sensitizer and agent used in the treatment of cardiac conditions
EP1258253A1 (en) * 2000-01-28 2002-11-20 Asahi Kasei Kabushiki Kaisha Novel remedies with the use of beta3 agonist
AU2001252575A1 (en) * 2000-04-28 2001-11-12 Asahi Kasei Kabushiki Kaisha Novel tricyclic compounds
AU2001252573A1 (en) * 2000-04-28 2001-11-12 Asahi Kasei Kabushiki Kaisha Novel substituted tricyclic compounds
WO2006132196A1 (ja) * 2005-06-08 2006-12-14 Asahi Kasei Pharma Corporation β３作動薬を含有する新規な医薬
US11053255B2 (en) 2015-06-22 2021-07-06 Georgetown University Synthesis of mahanine and related compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0170416B1 (ko) * 1990-02-09 1999-02-18 로버트 에이. 아미테이지 고혈압 치료를 위한 인슐린 증감제의 용도
ZA967892B (en) * 1995-09-21 1998-03-18 Lilly Co Eli Selective β3 adrenergic agonists.
ATE251608T1 (de) * 1996-01-10 2003-10-15 Asahi Chemical Ind Neue trizyklische verbindungen und arzneimittelzusammensetzungen die diese enthalten

Also Published As

Publication number Publication date
NO20012300D0 (no) 2001-05-10
JP2002529430A (ja) 2002-09-10
CA2350062A1 (en) 2000-05-18
TR200101336T2 (tr) 2001-11-21
WO2000027434A1 (en) 2000-05-18
EP1128845A1 (en) 2001-09-05
CZ20011655A3 (cs) 2002-06-12
AU766928B2 (en) 2003-10-23
NO20012300L (no) 2001-07-03
PL348154A1 (en) 2002-05-06
BR9915214A (pt) 2001-12-18
HK1041201A1 (zh) 2002-07-05
CN1332638A (zh) 2002-01-23
HUP0104388A3 (en) 2002-12-28
IL143004A0 (en) 2002-04-21
AU1063400A (en) 2000-05-29
HUP0104388A2 (hu) 2002-03-28

Similar Documents

Publication Publication Date Title
KR100666591B1 (ko) 티아졸리딘디온 및 메트포르민을 사용한 당뇨병의 치료
KR20030019440A (ko) 진성 당뇨병 치료를 위한 디펩티틸 펩티다제 ｉｖ 억제제및 다른 항당뇨병제의 병용제
JP2005213273A (ja) チアゾリジンジオン、インスリン分泌促進薬およびジグアニドを用いる糖尿病の治療
JP2005247865A (ja) チアゾリジンジオンおよびスルホニル尿素を用いる糖尿病の治療
KR20010075698A (ko) 베타 아고니스트 및 추가의 항당뇨병제를 포함하는 병용제
SK612000A3 (en) Application of insulin sensitiser, insulin secretagogue and alpha glucosidase inhibitor antihyperglycaemic agent for the treatment of diabetes mellitus and conditions associated with diabetes mellitus and a pharmaceutical composition
KR20010013840A (ko) 티아졸리딘디온 및 술포닐우레아를 사용한 당뇨병의 치료
US20030073644A1 (en) Combinations comprising a beta-agonist and a further antidiabetic agent
MXPA01004826A (en) Combinations comprising a beta-agonist and a further antidiabetic agent
US20030109561A1 (en) Treatment of diabetes with thiazolidinedione and sulphonylurea
ZA200103792B (en) Combinations comprising a beta-agonist and a further antidiabetic agent.
KR20010024482A (ko) 고혈당증 치료용 티아졸리딘디온의 용도
MXPA00003633A (en) Use of thiazolidinediones for the treatment of hyperglycaemia
MXPA00000633A (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide
MXPA00000655A (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor
MXPA00000631A (en) Treatment of diabetes with thiazolidinedione and sulphonylurea
KR20010024481A (ko) 고혈당증 치료용 티아졸리딘디온의 용도

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid